| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 33 | 12 | |
| Non-small cell lung cancer | 9 | 2 | |
| Adenosquamous carcinoma (non-small cell lung cancer) | 2 | 0 | |
| Pleomorphic carcinoma (non-small cell lung cancer) | 1 | 0 | |
| Unclassified carcinoma (non-small cell lung cancer) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 4 | |
| Fluid retention (edema) | 3 | |
| Mental fatigue or exhaustion | 2 | |
| Blood pressure fluctuates | 1 | |
| Bowel problems | 1 | |
| Leg pain with exertion | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 6 | |
| Mild | 4 | |
| None | 1 |